A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.

Vanderbilt will add a new race event, the 2013 Nashville Undy 5000, to the list of affiliated events for the upcoming fall season.

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.

Maury Regional Medical Center (MRMC) and Vanderbilt-Ingram Cancer Center (VICC) have joined forces to open a new radiation oncology treatment center for cancer patients in Spring Hill, Tenn.

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor.

On Tuesday, award-winning country music star Martina McBride and a group of her fans presented a check for $40,550 in support of cancer research at Vanderbilt-Ingram Cancer Center.